- Home
- SNTI vs WGRX Comparison
SNTI vs WGRX Comparison
Compare SNTI & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- WGRX
- Stock Information
- Founded
- SNTI 2016
- WGRX 2022
- Country
- SNTI United States
- WGRX United States
- Employees
- SNTI N/A
- WGRX N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- WGRX Other Pharmaceuticals
- Sector
- SNTI Health Care
- WGRX Health Care
- Exchange
- SNTI Nasdaq
- WGRX Nasdaq
- Market Cap
- SNTI 53.6M
- WGRX 60.2M
- IPO Year
- SNTI N/A
- WGRX 2025
- Fundamental
- Price
- SNTI $2.05
- WGRX $0.55
- Analyst Decision
- SNTI Strong Buy
- WGRX
- Analyst Count
- SNTI 4
- WGRX 0
- Target Price
- SNTI $8.75
- WGRX N/A
- AVG Volume (30 Days)
- SNTI 97.8K
- WGRX 4.3M
- Earning Date
- SNTI 11-13-2025
- WGRX 11-19-2025
- Dividend Yield
- SNTI N/A
- WGRX N/A
- EPS Growth
- SNTI N/A
- WGRX N/A
- EPS
- SNTI N/A
- WGRX N/A
- Revenue
- SNTI N/A
- WGRX $34,077,635.00
- Revenue This Year
- SNTI N/A
- WGRX N/A
- Revenue Next Year
- SNTI $150.00
- WGRX N/A
- P/E Ratio
- SNTI N/A
- WGRX N/A
- Revenue Growth
- SNTI N/A
- WGRX 495.93
- 52 Week Low
- SNTI $1.26
- WGRX $0.34
- 52 Week High
- SNTI $16.94
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- SNTI 56.53
- WGRX 45.34
- Support Level
- SNTI $1.44
- WGRX $0.44
- Resistance Level
- SNTI $2.16
- WGRX $0.71
- Average True Range (ATR)
- SNTI 0.18
- WGRX 0.07
- MACD
- SNTI 0.02
- WGRX 0.00
- Stochastic Oscillator
- SNTI 84.03
- WGRX 40.30
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.